Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-049804
Filing Date
2015-08-14
Accepted
2015-08-14 16:04:15
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v417012_10q.htm 10-Q 397814
2 EXHIBIT 31.1 v417012_ex31-1.htm EX-31.1 7582
3 EXHIBIT 31.2 v417012_ex31-2.htm EX-31.2 7505
4 EXHIBIT 32.1 v417012_ex32-1.htm EX-32.1 3858
5 EXHIBIT 32.2 v417012_ex32-2.htm EX-32.2 3825
  Complete submission text file 0001144204-15-049804.txt   4451179

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arni-20150630.xml EX-101.INS 1267458
7 XBRL TAXONOMY EXTENSION SCHEMA arni-20150630.xsd EX-101.SCH 47909
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20150630_cal.xml EX-101.CAL 20650
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20150630_def.xml EX-101.DEF 226020
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20150630_lab.xml EX-101.LAB 318145
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20150630_pre.xml EX-101.PRE 255135
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52153 | Film No.: 151055644
SIC: 2834 Pharmaceutical Preparations